4d Molecular Therapeutics
(NASDAQ) FDMT
4d Molecular Therapeutics Financials at a Glance
Market Cap
$500.82M
Revenue (TTM)
$85.21M
Net Income (TTM)
$140.11M
EPS (TTM)
$-2.51
P/E Ratio
-3.90
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$9.83
Volume
23,823
Open
$9.85
Price
$9.83
Volume
23,823
Open
$9.85
Previous Close
$9.83
Daily Range
$9.50 - $9.93
52-Week Range
$2.56 - $12.34
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$9.83
Volume
23,823
Open
$9.85
Previous Close
$9.83
Daily Range
$9.50 - $9.93
52-Week Range
$2.56 - $12.34
FDMT News
FDMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 4d Molecular Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
196
CEO
David H. Kirn, MD
Headquarters
EmeryVille, CA 94608, US
FDMT Financials
Key Financial Metrics (TTM)
Gross Margin
-14%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-28%
Return on Capital
-31%
Return on Assets
-25%
Earnings Yield
-25.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$500.82M
Shares Outstanding
51.05M
Volume
23.82K
Short Interest
0.00%
Avg. Volume
773.59K
Financials (TTM)
Gross Profit
$77.58M
Operating Income
$159.55M
EBITDA
$151.92M
Operating Cash Flow
$109.08M
Capital Expenditure
$536.00K
Free Cash Flow
$109.08M
Cash & ST Invst.
$402.65M
Total Debt
$21.41M
4d Molecular Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$85.09M
+8508900.0%
Gross Profit
$83.11M
+4761.2%
Gross Margin
97.67%
N/A
Market Cap
$500.82M
N/A
Market Cap/Employee
$2.21M
N/A
Employees
227
N/A
Net Income
$19.40M
+139.1%
EBITDA
$6.22M
+110.2%
Quarterly Fundamentals
Net Cash
$381.24M
-4.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.82M
-16.6%
Short Term Debt
$5.59M
-0.8%
Return on Assets
-24.72%
N/A
Return on Invested Capital
-30.52%
N/A
Free Cash Flow
$27.92M
+159.6%
Operating Cash Flow
$28.55M
+162.3%